| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.6M | +7.4% | +20.5% |
| Cost of Revenue | $5.8M | +16.5% | +8.9% |
| R&D Expense | $208K | -97.4% | -97.8% |
| SG&A Expense | $17.4M | -55.1% | -20.8% |
| Operating Income | -$6.8M | +81.3% | +69.2% |
| Interest Expense | $2.7M | +8.9% | -55.8% |
| Pre-tax Income | $8.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $86.2M | +15.9% | +46.5% |
| Accounts Receivable | $18.0M | +15.0% | +68.5% |
| Inventory | $11.8M | -8.0% | +0.3% |
| Current Assets | $118.5M | +7.3% | +37.4% |
| Total Assets | $181.4M | +13.5% | +42.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$53.2M | — | — |
| Investing Cash Flow | $10.1M | — | — |
| Financing Cash Flow | $71.7M | — | — |
| +176.0% |
| +133.3% |
| Income Tax | $26K | — | -62.3% |
| Net Income | $5.8M | -62.2% | +145.5% |
| EPS (Basic) | $0.13 | -74.0% | +117.1% |
| EPS (Diluted) | $0.11 | -75.6% | +114.5% |
| $54.1M |
| -6.0% |
| -23.1% |
| Long-term Debt | $47.8M | -4.5% | -9.0% |
| Total Liabilities | $116.2M | -5.1% | -16.9% |
| Stockholders' Equity | $55.9M | +27.2% | +164.0% |